Factors predicting survival in ALS: a multicenter Italian study

[1]  L. Casulari,et al.  Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study , 2015, PloS one.

[2]  D. Fan,et al.  Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  Rui Huang,et al.  The predictors of survival in Chinese amyotrophic lateral sclerosis patients , 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[4]  O. Hardiman,et al.  A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  Frans Nollet,et al.  Prognostic factors for the course of functional status of patients with ALS: a systematic review , 2014, Journal of Neurology.

[6]  M. Vinceti,et al.  Noninvasive and invasive ventilation and enteral nutrition for ALS in Italy , 2014, Muscle & nerve.

[7]  E. Granieri,et al.  Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[8]  Adriano Chiò,et al.  Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  J. Glass,et al.  Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997–2011 , 2013, Neurology. Clinical practice.

[10]  A. Chiò,et al.  Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009 , 2013, Journal of Neurology.

[11]  M. Sormani,et al.  Clinical epidemiology of ALS in Liguria, Italy , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[12]  P. Andersen,et al.  EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force , 2012, European journal of neurology.

[13]  M. Vinceti,et al.  Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[14]  A. Chiò,et al.  ALS clinical trials , 2011, Neurology.

[15]  O. Hardiman,et al.  The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  S. Paganoni,et al.  Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis , 2011, Muscle & nerve.

[17]  M. Sabatelli,et al.  Uncovering amyotrophic lateral sclerosis phenotypes: Clinical features and long-term follow-up of upper motor neuron-dominant ALS , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[18]  A. Chiò,et al.  Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  M. Benatar,et al.  Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease. , 2011, The Cochrane database of systematic reviews.

[20]  E. Beghi,et al.  The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[21]  A. Chiò,et al.  Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  D. Annane,et al.  Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease , 2010, The Cochrane database of systematic reviews.

[23]  F. Khan,et al.  Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease. , 2009, The Cochrane database of systematic reviews.

[24]  E. Beghi,et al.  Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[25]  E. Beghi,et al.  Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[26]  P. Shaw,et al.  Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial , 2006, The Lancet Neurology.

[27]  W. McGuire,et al.  Iron supplementation in enterally fed preterm infants , 2005 .

[28]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[29]  M. de Carvalho.  Natural history of young-adult amyotrophic lateral sclerosis. , 2009, Neurology.

[30]  Robert G. Miller,et al.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). , 2007, The Cochrane database of systematic reviews.

[31]  H. Mitsumoto,et al.  Subcommittee of the American Academy of Neurology Evidence-based Review) : Report of the Quality Standards Management, and Cognitive/behavioral Impairment (an Amyotrophic Lateral Sclerosis: Multidisciplinary Care, Symptom Practice Parameter Update: the Care of the Patient With , 2022 .